Understanding ICH Guidelines for Nitrosamine Impurities in Pharmaceuticals
Introduction: The Growing Concern of Nitrosamine Impurities in Pharmaceuticals In recent years, the presence of nitrosamine impurities in pharmaceutical products has become a significant concern due to their potential carcinogenic effects. As regulatory agencies, including the FDA and EMA, have heightened scrutiny over these impurities, the International Council for Harmonisation (ICH) has provided guidelines to […]






